RespirAI is transforming chronic respiratory care with the first AI-powered home monitoring platform that leverages FDA-approved off-the-shelf sensors and a proprietary patented algorithm to track disease status and predict life-threatening flare-ups early. This enables timely intervention, reduces hospitalizations, and saves lives. Initially focused on COPD, RespirAI is driving better outcomes through personalized, proactive care at home.